Precision BioSciences, Inc. Common Stock

DTILNASDAQ • USD
7.58 USD
↗ 0.01 (0.13%)🟢PRE MARKET (AS OF 04:00 AM EST)
🟢Market: OPEN

DTIL is currently priced at $7.58. DTIL shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Furthermore, DTIL is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Nov 13, 2026.

Open?$7.58
High?$7.58
Low?$7.58
Prev. Close?$7.57
Volume?0
Avg. Volume?378.4K
Bid / Ask
Bid?$6.48 × 100
Ask?$9.07 × 100
Spread?$2.59
Midpoint?$7.78
Valuation & Ratios
Market Cap?289.0M
Shares Out?27.9M
Float?25.9M
Float %?94.0%
P/E Ratio?N/A
P/B Ratio?5.58
EPS?-$1.10
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
Employees
69
Market Cap
288.8M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2019-03-28
Address
302 EAST PETTIGREW STREET
DURHAM, NC 27701
Phone: 919-314-5512
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
53
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.54Distress
Confidence?54%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?8.08%Elevated
Short Interest?2.1M
Days to Cover?10.5
Free Float25.9M
Avg Daily Volume199.4K
Settlement Date2026-10-30
Financial Health
Current Ratio?10.47Strong
Quick Ratio?10.47Strong
Cash Ratio?9.88Strong
Debt/Equity?0.43Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
33
5.58FAIR▾
P/S?
Peers
100
S&P
11
8.44HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.9CHEAP▾
EV/Sales?
Peers
100
S&P
22
6.71HIGH▾
Returns & Efficiency
ROE?
S&P
3
-80.9%WEAK▾
ROA?
S&P
3
-34.8%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$229.7M
Fundamentals ratios updated end of day